Ortho Clinical Diagnostics Holdings plc
NASDAQ:OCDX
| Market Cap (Intraday) | 3.97B |
| Current PE | N/A |
| Forward PE | 25.44 |
| 2yr Forward PE | 21.99 |
| 10-Day MA | $18.81 |
| 50-Day MA | $20.34 |
| 200-Day MA | N/A |
Ortho Clinical Diagnostics Holdings plc Stock, NASDAQ:OCDX
1001 Route 202, Raritan, New Jersey 08869
United States of America
Phone: +1.908.218.8000
Number of Employees: 4500
Description
Ortho Clinical Diagnostics Holdings Plc provides vitro diagnostics services. It offers VITROS XT 7600 Integrated System, VITROS 5600 Integrated System, VITROS 4600 Chemistry System, VITROS�® XT 3400 Chemistry System, VITROS�® 3600 Immunodiagnostic System, VITROS ECiQ Immunodiagnostic System, VITROS Automation Solutions, Informatics Solutions, Assay Menu by Disease State, Microtip Partnership Assays, VITROS HIV Combo Test, Transfusion Medicine, ORTHO VISION Analyzer, ORTHO VISION Max Analyzer, ORTHO CONNECT, ORTHO Workstation, Lab Reliability, Lab Optimization, Training & Education and Lab Support. The company is headquartered in Raritan, NJ.